# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-015820
Filing Date
2023-09-15
Accepted
2023-09-15 16:35:26
Documents
21
Period of Report
2023-11-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | pahc-20231106xdef14a.htm iXBRL | DEF 14A | 1145077
2 | GRAPHIC | pahc-20231106xdef14a_a003.jpg | GRAPHIC | 10068
3 | GRAPHIC | pahc-20231106xdef14a_a004.jpg | GRAPHIC | 5247
4 | GRAPHIC | pahc-20231106xdef14a_a012.jpg | GRAPHIC | 64680
5 | GRAPHIC | pahc-20231106xdef14a_a013.jpg | GRAPHIC | 62610
6 | GRAPHIC | pahc-20231106xdef14a_a014.jpg | GRAPHIC | 61556
7 | GRAPHIC | pahc-20231106xdef14a_a015.jpg | GRAPHIC | 42728
8 | GRAPHIC | pahc-20231106xdef14a_bg001.jpg | GRAPHIC | 163845
9 | GRAPHIC | pahc-20231106xdef14a_cg001.jpg | GRAPHIC | 107664
| Complete submission text file | 0001558370-23-015820.txt |  | 3074131

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | pahc-20231106.xsd | EX-101.SCH | 6641
11 | EX-101.DEF | pahc-20231106_def.xml | EX-101.DEF | 49656
12 | EX-101.LAB | pahc-20231106_lab.xml | EX-101.LAB | 7153
13 | EX-101.PRE | pahc-20231106_pre.xml | EX-101.PRE | 5668
16 | EXTRACTED XBRL INSTANCE DOCUMENT | pahc-20231106xdef14a_htm.xml | XML | 136264

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 231259199
SIC: 2834 Pharmaceutical Preparations